公司概覽
業務類別 Diagnostics & Research
業務概覽 Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry,and it serves biopharmaceutical firms, providers, payers, and policymakers.
公司地址 2400 Ellis Road, Durham, NC, USA, 27703
電話號碼 +1 919 998-2000
傳真號碼 --
公司網頁 https://www.iqvia.com
員工數量 93000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Ari Bousbib Chairman of the Board and Chief Executive Officer 美元 1.80M 27/02/2026
Mr. Michael J. Fedock Executive Vice President and Chief Financial Officer -- 17/02/2026
Ms. Keriann Cherofsky Senior Vice President, Chief Accounting Officer and Corporate Controller -- 17/02/2026
Mr. Alistair Grenfell President, Commercial Solutions 美元 629.91K 27/02/2026
Mr. Eric M. Sherbet Executive Vice President, General Counsel and Secretary 美元 665.00K 17/02/2026
Mr. Bernd Haas Executive Vice President, AI and Technology Solutions -- 17/02/2026
Mr. Bhavik Patel President, MedTech and Consumer Health -- 17/02/2026
Mr. James G. Berkshire Executive Vice President, Global Infrastructure and Operations -- 17/02/2026
Mr. W. Richard Staub, III President, Research and Development Solutions -- 17/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Ari Bousbib Chairman of the Board and Chief Executive Officer 27/02/2026
Mr. John G. Danhakl Independent Director 27/02/2026
Ms. Colleen A. Goggins Independent Director 27/02/2026
Ms. Carol J. Burt Independent Director 27/02/2026
Mr. Todd B. Sisitsky Independent Director 27/02/2026
Dr. John M. Leonard, M.D. Lead Independent Director 27/02/2026
Ms. Sheila A. Stamps Independent Director 27/02/2026
Mr. James A. Fasano Independent Director 27/02/2026
Dr. William G. Kaelin, Jr,M.D. Independent Director 27/02/2026
Ms. Leslie Wims Morris Independent Director 27/02/2026
 
所屬ETF (更新日期: 02/05/2026 02:33)
代號 名稱 佔比% 持有日期
JAVAJPMorgan Active Value ETF0.08%29/04/2026
VTVanguard Total World Stock ETF0.08%31/03/2026
OAKMOakmark U.S. Large Cap ETF0.07%29/04/2026
IWBiShares Russell 1000 ETF0.07%29/04/2026
DFUVDimensional US Marketwide Value ETF0.06%29/04/2026
JGROJPMorgan Active Growth ETF0.06%29/04/2026
VONVVanguard Russell 1000 Value ETF0.06%31/03/2026
SCHBSchwab US Broad Market ETF™0.06%29/04/2026
FNDXSchwab Fundamental U.S. Large CompanyETF0.06%29/04/2026
BBHVanEck Biotech ETF0.06%29/04/2026
IYHiShares US Healthcare ETF0.05%29/04/2026
JDVLJHancock Disciplined Value Select ETF0.05%29/04/2026
IXJiShares Global Healthcare ETF0.05%28/04/2026
GSLCGoldman Sachs ActiveBeta® US LgCp Eq ETF0.05%29/04/2026
DFLVDimensional US Large Cap Value ETF0.05%29/04/2026
FHLCFidelity MSCI Health Care ETF0.05%29/04/2026
RSPHInvesco S&P 500® Equal Wt Hlth Care ETF0.04%29/04/2026
RECSColumbia Research Enhanced Core ETF0.04%04/02/2026
JHMMJHancock Multifactor Mid Cap ETF0.04%29/04/2026
SUSAiShares ESG Optimized MSCI USA ETF0.04%29/04/2026
  1   2    3    4    5    6    7    8    9    10    11    12    13    14    15    16  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.